Plasminogen

Papers on Plasminogen

328 papers17 new in 30 days

Wednesday, November 18

Thursday, November 12

Monday, November 9

AHA Scientific Sessions 2026 Abstract

Statin use linked to lower cardiovascular risk at high marker levels

Compared with nonuse, statin use was linked to a 35% lower relative cardiovascular event rate in adults in the highest third for an inflammation marker.Compared with nonuse, statin use was linked to a 35% lower relative cardiovascular event rate in adults in the highest third for an inflammation marker.

A large heart with a small damaged patch sits beside a smaller, more scarred heart, both surrounded by blood cells and dark protein clusters.
Cohort · 3,914 peopleCardiovascular disease
AHA Scientific Sessions 2026 Abstract

Urinary cadmium linked to higher blood inflammation marker

Each increase spanning the middle half of urinary cadmium measurements was linked to 7.81% higher levels of a marker of chronic inflammation.Each increase spanning the middle half of urinary cadmium measurements was linked to 7.81% higher levels of a marker of chronic inflammation.

Blood samples contain sparse or dense inflammation markers, beside urine samples with correspondingly few or many cadmium specks.
Cohort · 5,178 peoplePopulations
AHA Scientific Sessions 2026 Abstract

Enicepatide linked to lower abdominal fat markers across ages

At 48 weeks, waist circumference fell 11.6%, 12.4% and 14.3% at increasing enicepatide doses, compared with 1.5% with placebo.At 48 weeks, waist circumference fell 11.6%, 12.4% and 14.3% at increasing enicepatide doses, compared with 1.5% with placebo.

Abdominal cross-sections show intestinal folds surrounded by dense fat in a broad waist and sparse fat in a slimmer waist.
Randomized trial · 467 peopleInterventions

Saturday, November 7

Monday, November 2

Journal of the American Heart Association

Urinary cadmium linked to higher immune marker levels

An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.

Blood cells amid sparse and dense immune markers sit beside groups of people and urine droplets containing fewer or more metal flecks.
Cohort · 5,148 peoplePopulations

Thursday, October 29

Wednesday, October 28

bioRxiv

Immune signals linked to physical frailty in people

Blood analyses in two aging cohorts of 22 and 33 people linked physical frailty to immune signals involved in cell movement and inflammation.Blood analyses in two aging cohorts of 22 and 33 people linked physical frailty to immune signals involved in cell movement and inflammation.

Study design and derivation of age-adjusted TUG residuals.
Preprint: cohort · 55 peopleImmune response

Monday, October 26

ESC Congress 2026 Abstract

Targeted drug carriers reduced artery calcium buildup in mice

Tiny carriers delivered two cell-clearing drugs in two mouse models, improving survival and avoiding blood-cell side effects associated with dasatinib given without…Tiny carriers delivered two cell-clearing drugs in two mouse models, improving survival and avoiding blood-cell side effects associated with dasatinib given without carriers.

Artery cross-sections show dense calcium deposits beside a clearer wall, with small round drug carriers and a laboratory mouse nearby.
Mouse studyInterventions

Friday, October 2

Monday, September 28

Friday, September 25

Sunday, September 20

Friday, September 11

Thursday, September 3

Monday, August 31

Wednesday, August 26

Sunday, August 23

Thursday, August 20

Alzheimer's & Dementia

Four blood proteins linked to cognitive decline and death

In 518 memory-clinic participants followed for up to four years, the proteins also predicted major heart or stroke-related events.In 518 memory-clinic participants followed for up to four years, the proteins also predicted major heart or stroke-related events.

Overview of study. CeVD, cerebrovascular disease; MACCE, major adverse cardiovascular or cerebrovascular events.
Cohort · 2,534 peopleBiomarkers

Tuesday, August 11

Monday, August 10

Monday, August 3